Guidelines
The ICMS standards of lab practice for the minimal culture of A-ASCs.
The ICMS standards of clinical practice for therapy involving the harvesting, minimal expansion of, and re-implantation of A-ASCs.
ICMS Re-Implantation Registry Guidelines
ICMS has published a first of its kind set of guidelines to define the standards for the monitoring and tracking of results and complications of autologous stem cell therapy.
ICMS Guidelines for the Use of Platelet Rich Plasma (PRP) - DRAFT
The International Cellular Medical Society (ICMS) asserts that a need exists to create standards for platelet rich plasma (PRP) protocols, preparations, techniques and tracking. We believe that physician-led organizations will serve the needs and interests of both patients and physicians toward achieving the best outcomes. In order to advance PRP in particular (and autologous cellular medicine therapies in general), we have developed these guidelines to assist physicians in performing safe therapies, promote patient education, encourage robust clinical research and begin to define the scope and anticipated effects of these procedures.
To participate in an ICMS Advisory Councils and to help guide the future of cell medicine, click HERE
|
|
|
|
